A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 2, 2003, Pages 562-568

  Gu, Yi Qun ^a   Wang, Xing Hai ^b   Xu, Dwo ^c   Peng, Lin ^d   Cheng, Li Fa ^e   Huang, Ming Kong ^f   Huang, Zhen Jia ^g   Zhang, Gui Yuan ^a  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b Jiangsu Family Planning Institute   (China)

^c Hebei Research Institute for Family Planning   (China)

^d Yunnan Research Institute of Family Planning   (China)

^e Henan Research Institute for Population and Family Planning   (China)

^f Sichuan Family Planning Research Institute   (China)

^g Shandong Institute for Family Planning   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; AZOOSPERMIA; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; FOLLITROPIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OLIGOSPERMIA; OPEN STUDY; PAIN; PHASE 2 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL;

ADULT; CHINA; CHOLESTEROL, HDL; CONTRACEPTIVE AGENTS, MALE; FOLLICLE STIMULATING HORMONE; HEMATOCRIT; HEMOGLOBINS; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PILOT PROJECTS; SPERM COUNT; SPERMATOGENESIS; TESTOSTERONE;

EID: 0037326027     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020447     Document Type: Article

References (22)

1. Paulsen CA, Leonard JM, Burges EC, Ospina LF 1978 Male contraceptive development; re-examination of testosterone enanthate as an effective single entity agent. In: Patanelli DJ, eds. Hormonal control of male fertility. Bethesda: DHEW, NIH; 17-40
2. Swerdloff RS, Palacios A, McClure RD, Campfield LA, Brosmen SA 1978 Clinical evaluation of testosterone enanthate in the reversible suppression of spermatogenesis in the human male: efficacy, mechanism of action, and adverse effects. In: Patanelli DJ, eds. Hormonal control of male fertility. Bethesda: DHEW, NIH; 41-70
3. Cunningham GR, Silverman VE, Kohler PO 1978 Clinical evaluation of testosterone enanthate for induction and maintenance of reversible azoospermia in men. In: Patanelli DJ, eds. Hormonal control of male fertility. Bethesda: DHEW, NIH; 71-92
4. Mauss J, Borsch G, Bormacher K, Richter E, Leyendecker G 1978 Seminal fluid analyses, serum FSH, LH and testosterone in seven males before, during and after 250 mg testosterone enanthate weekly over 21 weeks. In: Patanelli DJ, eds. Hormonal control of male fertility. Bethesda: DHEW, NIH; 93-122
5. WHO Task Force for the Regulation of Male Fertility 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955-959
6. WHO Task Force for the Regulation of Male Fertility 1996 Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821-829
7. Li MH, Guo SB, Fang RY, Zhang YP 1994 Pharmacological and clinical effects of testosterone undecanoate. N Drugs Clin Remedies 13:279-281
8. Chen ZD, Liu JD Kong ZL, Huang YZ, Jiang RG, Ren FJ, Huang LM, Shen ZJ, Zhu XW, Sur GH 1991 Clinical studies on therapeutical efficacy of TU in the treatment of patients with sexual dysfunction and male infertility. J Zhejiang Med Univ 20:126-129
9. Partsch CJ, Weinbauer GF, Fang RY, Nieschlag E 1995 Injectable testosterone undecanoate has more favorable pharmacokinetics and pharmacodynamics than testosterone enanthate. Eur J Endocrinol 132:514 519
10. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ 1998 A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. J Androl 19:761-768
11. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ 1999 A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84:3642-3647
12. World Health Organization 1992 WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 3rd Ed. Cambridge: Cambridge University Press
13. Zhang GY, Xiao BL, Chen ZW, Zhu JC, Meng GD 1985 Dynamic study of serum gonadotrophin and testosterone levels in gossypol-treated men. Long-term follow-up study of 60 cases. Int J Androl 8:177-185
14. Wang CCL 1999 Clinical studies using androgen alone for male contraceptive development. In: Rajalakshmi M, Griffin PD, eds. Male contraception: present and future. New Delhi, India: New Age International; 189-200
15. Wu FCW, Farley TMM, Peregoudov A, Waites GMH, World Health Organization Task Force for the Regulation of Male Fertility 1996 Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. Fertil Steril 65:626-636
16. Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E 1995 Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab 80:2394-2403
17. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ 1994 Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 9:561-567
18. Meriggiola MC, Marcovina S, Paulsen CA, Bremner WJ 1995 Testosterone enanthate at a dose of 200 mg/week decrease HDL cholesterol levels in healthy men. Int J Androl 18:237-242
19. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA 1996 Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 81:4113-4121
20. Nieschlag E, Buchter D, Von Eckardstein S, Abshagen K, Simoni M, Behre HM 1999 Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf) 51:757-763
21. Kamischke A, Venherm S, Ploger D, von Eckardstein S, Nieschlag E 2001 Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab 86:303-309
22. Kamischke A, Heuermann T, Kruger K, von Eckardstein S, Schellschmidt I, Rubig A, Nieschlag E 2002 An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab 87:530-539